Literature DB >> 15742999

Intestinal tissue transglutaminase in coeliac disease of children and adults: ultrastructural localization and variation in expression.

H Skovbjerg1, G H Hansen, L L Niels-Christiansen, D Anthonsen, H Ascher, G Midhagen, C Hallert, O Norén, H Sjöström.   

Abstract

BACKGROUND: Tissue transglutaminase is the main antigen for the anti-endomysial antibodies used for diagnosis of coeliac disease and can with some specificity in vitro deamidate gliadins generating potent epitopes. The intestinal levels and the ultrastructural localization of tissue transglutaminase in normal and affected persons were investigated to provide further information on its role in this disease. Intestinal biopsies were taken from normal and coeliac children and adults.
METHODS: The level of transglutaminase was analysed by means of a quantitative enzymatic assay and its ultrastructural localization by immunogold electronmicroscopy using a monoclonal antibody against tissue transglutaminase.
RESULTS: In relation to normal individuals, the enzymatic activity of tissue transglutaminase in adult coeliac patients was increased. The enzyme was found in the enterocytes and in increased amount just beneath the enterocytes, where cytosolic and nuclear labelling of distinct elongated cells was seen in addition to extracellular labelling close to collagen fibrils. In children, the enzymatic activity and the immunogold labelling could not be shown to be related to disease. In all cases the enzyme activity was EDTA-sensitive.
CONCLUSIONS: The increased amount of tissue transglutaminase activity in coeliac adults was shown to be due to the appearance of the enzyme in enterocytes and increased expression in the lamina propria. No evidence was found to support the idea of a changed localization or changed amounts as primary elements in coeliac disease pathogenesis, nor for the involvement of non-calcium dependent microbial transglutaminases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15742999     DOI: 10.1080/00365520410003597

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  8 in total

Review 1.  [Dermatitis herpetiformis. An update of the pathogenesis].

Authors:  M Sárdy; J Tietze
Journal:  Hautarzt       Date:  2009-08       Impact factor: 0.751

Review 2.  Genetic and Environmental Contributors for Celiac Disease.

Authors:  Gloria Serena; Rosiane Lima; Alessio Fasano
Journal:  Curr Allergy Asthma Rep       Date:  2019-07-18       Impact factor: 4.806

3.  Immunological indicators of coeliac disease activity are not altered by long-term oats challenge.

Authors:  S E J Cooper; N P Kennedy; B M Mohamed; M Abuzakouk; J Dunne; G Byrne; G McDonald; A Davies; C Edwards; J Kelly; C F Feighery
Journal:  Clin Exp Immunol       Date:  2013-03       Impact factor: 4.330

4.  Serological and clinical comparison of children and adults with anti-endomysial antibodies.

Authors:  Branka Bonaci-Nikolic; Sladjana Andrejevic; Nedeljko Radlovic; Ivana Davidovic; Ljiljana Sofronic; Milan Spuran; Marjan Micev; Milos M Nikolic
Journal:  J Clin Immunol       Date:  2007-01-23       Impact factor: 8.317

5.  Celiac disease in patients with type 1 diabetes: a condition with distinct changes in intestinal immunity?

Authors:  Raivo Uibo; Marina Panarina; Kaupo Teesalu; Ija Talja; Epp Sepp; Meeme Utt; Marika Mikelsaar; Kaire Heilman; Oivi Uibo; Tamara Vorobjova
Journal:  Cell Mol Immunol       Date:  2011-02-14       Impact factor: 11.530

6.  Deamidation of gliadin peptides in lamina propria: implications for celiac disease.

Authors:  H Skovbjerg; D Anthonsen; E Knudsen; H Sjöström
Journal:  Dig Dis Sci       Date:  2008-08-05       Impact factor: 3.199

7.  Tissue transglutaminase expression in celiac mucosa: an immunohistochemical study.

Authors:  Julia Gorgun; Anna Portyanko; Yuri Marakhouski; Eugeni Cherstvoy
Journal:  Virchows Arch       Date:  2009-09-12       Impact factor: 4.064

8.  Mucosal tissue transglutaminase expression in celiac disease.

Authors:  Vincenzo Villanacci; Tarcisio Not; Daniele Sblattero; Tiziano Gaiotto; Fernando Chirdo; Anna Galletti; Gabrio Bassotti
Journal:  J Cell Mol Med       Date:  2008-03-28       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.